1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof

Inactive Publication Date: 2005-07-07
GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D O O
View PDF9 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Said drugs act symptomatically, but they do not stop the pathological process.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
  • 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
  • 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof

Examples

Experimental program
Comparison scheme
Effect test

example 2

1H-8-Oxa-1-aza-dibenzo[e,h]azulene-2-carbaldehyde (7)

[0097] To dimethylformamide (38.7 mmol) cooled to 0° C., phosphoric trichloride (25.7 mmol) was added drop by drop and then the reaction mixture was stirred at room temperature for 15 minutes. To the reaction mixture cooled again to 0° C., a dimethylformamide solution of 1H-8-oxa-1-aza-dibenzo[e,h]azulene (4, 2.57 mmol in 5 mL) was added. Then the reaction mixture was stirred at 70-80° C. for 1-2 hours, cooled to room temperature and, by adding 50% NaOH, the pH was adjusted to 8-9. Such alkaline solution was heated for 1 hour at 70° C., then cooled to room temperature and poured into an ice-water mixture. The organic product was extracted with ethyl acetate, purified by chromatography on silica gel column and a yellow oily product was isolated.

[0098] According to the above process, by formylation of the compounds 5 and 6 there were prepared the compounds [0099] 11-chloro-1H-8-oxa-1-aza-dibenzo[e,h]azulene-2-carbaldehyde (8) and ...

example 3

1-(2-Trimethylsilyl-ethoxymethyl)-1H-8-oxa-1-aza-dibenzo[e,h]azulene-2-carbaldehyde (10)

[0100] A tetrahydrofuran solution of 1H-8-oxa-1-aza-dibenzo[e,h]azulene-2-carbaldehyde (7; 1.9 mmol in 15 mL) was cooled to 0° C. and slowly sodium hydride (60% dispersion in mineral oil, 125 mg) was added thereto. The reaction mixture was stirred at 0° C. until hydrogen stopped to develop (15-30 minutes) and trimethylsilyl ethoxymethyl chloride, (CH3)3SiCH2CH2OCH2Cl (SEM-Cl; 2 mmol) was added to the cooled reaction mixture. The reaction mixture was stirred at room temperature for one hour and then it was diluted by addition of water. The organic product was extracted with ethyl acetate. After drying the organic extracts on anhydrous sodium sulfate and evaporating the solvent, the crude product was purified by chromatography on a silica gel column. A dark oily product was isolated.

[0101] According to the above process, by silylating the compounds 8 and 9 there were prepared the compounds [0102]...

example 4

[1-(2-Trimethylsilyl-ethoxymethyl)-1H-8-oxa-1-aza-dibenzo[e,h]azulene-2-yl]-methanol (13)

[0104] To a methanolic solution of 1-(2-trimethylsilanyl-ethoxymethyl)-1H-8-oxa-1-aza-dibenzo[e,h]azulene-2-carbaldehyde (10; 2.45 mmol in 25 mL), NaBH4 (4 mmol) was added and the reaction mixture was stirred at room temperature for 2 hours. Then the pH of the reaction mixture was adjusted to 5 by adding acetic acid, the solvent was evaporated to dryness and the dry residue was extracted with ethyl acetate. By purifying the crude product by chromatography on a silica gel column an oily product was isolated.

[0105] According to the above process, by reacting the compounds 11 and 12 with NaBH4 there were prepared the compounds [0106] [11-chloro-1-(2-trimethylsilyl-ethoxymethyl)-1H-8-oxa-1-aza-dibenzo[e,h]azulene-2-yl]-methanol (14) and

[0107] [1-(2-trimethylsilyl-ethoxymethyl)-1H-8-thia-1-aza-dibenzo[e,h]azulene-2-yl]-methanol (15).

TABLE 1Icmp.XYZR1R2MS(m / z)1H NMR (ppm, CDCl3)4OHHHH231.96.59 (t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
volumeaaaaaaaaaa
Login to view more

Abstract

The present invention relates to 1-aza-dibenzoazulene derivatives, to their pharmacologically acceptable salts and solvates, to processes and intermediates for the preparation thereof as well as to their antiinflammatory effects, especially to the inhibition of tumour necrosis factor-α (TNF-α) production and the inhibition of interleukin-1 (IL-1) production as well as to their analgetic action.

Description

TECHNICAL FIELD [0001] The present invention relates to 1-aza-dibenzoazulene derivatives, to their pharmacologically acceptable salts and solvates, to processes and intermediates for the preparation thereof as well as to their antiinflammatory effects, especially to the inhibition of tumour necrosis factor-α (TNF-α) production and the inhibition of interleukin-1 (IL-1) production as well as to their analgetic action. PRIOR ART [0002] There are numerous literature data relating to various aza- and diaza-dibenzoazulenes and to the preparation thereof. It is well-known that some compounds of such structure and salts thereof have an antiinflammatory action and represent a novel class of compounds having such an action. Thus in a series of patents (U.S. Pat. No. 3,711,489, U.S. Pat. No. 3,781,294 and CA 967,573) the preparation of dibenzoazulenes of imidazole class with various 2-substituents such as trifluoromethyl, pyridyl, naphthyl, phenyl and substituted phenyl is disclosed. There we...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): C07D491/044A61K31/4025A61K31/407A61K31/55A61K31/695A61P1/04A61P11/06A61P17/00A61P17/04A61P19/02A61P19/08A61P27/02A61P29/00A61P43/00C07D209/70C07D491/02C07D491/04C07D495/04C07D498/02C07F7/08
CPCC07D495/04C07D491/04A61P1/04A61P11/06A61P17/00A61P17/04A61P19/02A61P19/08A61P27/02A61P29/00A61P43/00Y02P20/55
Inventor MERCEP, MLADENMESIC, MILANPESIC, DIJANA
Owner GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D O O
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap